Cantel Medical Corp. Employment Offer Letter to George Fotiades for President and CEO Position

March 2, 2019

George Fotiades

281 Summit Ave.

Summit, New Jersey 07901

Re: Offer of Employment

Dear Mr. Fotiades:

Cantel Medical Corp. is pleased to offer you employment in the position of President and Chief Executive Officer, based out of our offices in Little Falls, New Jersey. In this position, you will report to the Board of Directors of Cantel. It is anticipated that your start date will be March 4, 2019.

In addition to your position as President and CEO, you will continue to serve as a director on Cantel’s Board of Directors. As you will no longer be deemed an independent director, you will not serve as a member of any Board committee. In addition, you will not receive any compensation as a director.

    

Your starting annual salary will be $850,000, paid bi-weekly (less applicable taxes, withholdings and deductions). This position is considered exempt from the overtime provisions of state and federal wage and hour laws.

In addition, you will be eligible to participate in Cantel’s Management Incentive Compensation Program (MICP). Your MICP bonus target level will be set at 100% of your base salary, pro-rated in the first fiscal year according to the MICP Terms and Conditions. Your MICP bonus for FY2019 will be performance-based consistent with the MICP metrics applicable to other executive officers of the Company. A more detailed description of the MICP bonus target is set forth in the FY2019 Executive Compensation Memo accompanying this letter (the “Compensation Memo”).

Effective as of your start date, you will receive restricted stock units (“RSUs”) having an aggregate value of $2.6 million based on the closing price of Cantel stock on the NYSE on the first business day immediately preceding your start date. One-half of the RSUs will be time-based, vesting over the 3-year period commencing on the first anniversary of the grant date. The other half will be performance-based consistent with the performance metrics of the LTI awards granted to executives in October 2018. The performance-based RSUs will vest on October 10, 2021. All of the awards are subject to the terms and conditions of the RSU Agreements covering the LTI grants as well as the Company’s 2016 Equity Incentive Plan. A more detailed description of the above stock awards is set forth in the Compensation Memo.

Subject to formal approval of the Compensation Committee, commencing in October 2019 you will be eligible for annual RSU awards. It is anticipated that the October 2019 grants will be comprised of both time-based and performance-based RSUs with an aggregate value of not less than $2.6 million. The performance-based RSUs will have criteria determined by the Compensation Committee. The RSU awards will be subject to the terms and conditions of the related RSUs grant agreement and the 2016 Equity Incentive Plan, as well as any additional terms and conditions determined by the Compensation Committee.

Subject to the eligibility requirements and other terms and conditions of the various benefits policies and plans, you will enjoy certain additional employee benefits such as:

After you begin employment, you will be provided with additional information regarding the company’s benefits policies and plans. The company reserves the right to amend, modify or terminate (in whole or in profit) its benefits policies and plans.

If you accept this offer of employment, you agree that your employment will at all times be at-will, which means that you and the company are both free to terminate the employment relationship at any time, with or without cause. You will have no guaranteed or definite period of employment. Although your job duties, title, compensation rate, benefits and other terms and conditions of your employment and the company’s various policies, procedures and plans may change from time to time, the “at-will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the company. Additionally, as an employee, you will be required to comply with all applicable rules, policies and procedures of the company, including, but not limited to, those set forth in the Employee Handbook.

This offer of employment and any subsequent employment by the company are contingent upon, among other things, the following: receipt of a counter-signed and dated original of this offer letter and the enclosed Confidentiality, Non-Solicitation and Inventions Agreement; attainment of satisfactory results (as determined by the company) on drug screening.

This offer letter supersedes and replaces any and all prior offers and/or agreements regarding your employment with the company. By accepting this offer, you acknowledge and agree that you are not relying on any statements, promises or representations (oral or written) made by any employee, agent or representative of the company that are not expressly set forth in this letter. Additionally, by signing this offer letter and accepting this offer of employment, you represent and warrant that you are not subject to any kind of non-competition covenant or agreement that would prohibit you from being employed by the company and/or performing the duties of the position offered to you in this offer letter.

If you would like to accept this offer, please counter-sign and date this offer letter in the spaces provided below and sign and date the enclosed Confidentiality, Non-Solicitation and Inventions Agreement and return both original documents to me. Please retain copies for your files. If you have any questions or require additional time to consider this offer, please do not hesitate to contact me.

_________________________________        _____________________

George Fotiades                     Date